compounded tirzepatide vs non compounded Explained: Key Facts to Know Compounded GLP-1 & GIP

These patients had a body mass index (BMI) falling within the range of 35 to 39.9, placing them within the category of obesity (BMI of 30 or higher)

Data Imputation Methods A number of imputation methods were used across trials to account for missing data, including multiple imputation using retrieved patients, jump to reference multiple imputation, and single imputation as done by Sacks

The SURMOUNT clinical trials demonstrated that tirzepatide produces weight loss of 15-22% of baseline body weight over 68 weeks, with higher doses generally showing greater effects than lower doses

By using a combination of lower doses of both medications, patients might be able to minimize these side effects while still achieving weight loss